Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Alkermes (ALKS – Research Report) today and set a price target of $36.00. The ...
In a report released today, Benjamin Burnett from Stifel Nicolaus maintained a Buy rating on Disc Medicine (IRON – Research Report), with a ...
Good day and welcome to the Stifel Financial fourth quarter financial results conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr ...
What should I know about this firm? Stifel, Nicolaus & Co. Inc. offers investment advising services that let individuals choose the level of control they have over their portfolio. Everyday ...
Hosted on MSN25d
Stifel defends FTAI Aviation stock after short report, sees upside from key catalystsOn Thursday, Stifel analysts reiterated their Buy rating on FTAI Aviation (NASDAQ:FTAI) stock, with a price target of $167.00. The stock has experienced significant volatility recently ...
Stifel analyst Stephen Gengaro downgraded Canoo (GOEV) to Hold from Buy with a price target of 50c, down from $4.50. The firm cites the company’s need for capital and its recent announcement ...
Stifel has initiated coverage of Cytokinetics (NASDAQ:CYTK) with a buy rating, citing its drug aficamten. The bank noted the stock was "out of favor" in the wake of a "controversial" deal with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback